Ann: Open Briefing, page-5

Although they are aiming for $4m, however I believe they will continue with whatever they could get. So future CR is not unthinkable if they do not hit the target. Apart from giving them some breathing space, I don't think capital raising will solve the fundamental problem. That is, even if they get a new client it takes months to generate any decent revenue from them. Meanwhile everyone needs to draw salaries. Not sure what alternate strategy they can adopt at this point. Maybe offer bigger incentives to Labcon and other distributors. Revenue is the key now. Shareholders can fund short term loss if they can see revenue is growing. Lab numbers have only grown by 4 or 5 since March 2023 as per the chart provided. 5 new labs in 11 months with all that sales and marketing spend, how can anyone believe their growth story?